The genetic toxicology of acridines

LR Ferguson, WA Denny - Mutation Research/Reviews in Genetic …, 1991 - Elsevier
Summary 1 lntroducuon 2 Classification and physlcochemlcal properties of acridines 2 1 9-
Anunoacndme and related compounds 2 2 Proflavme and related compounds 2 3 …

DNA modification by chemical carcinogens

AM Jeffrey - Pharmacology & therapeutics, 1985 - Elsevier
There are to date about six million compounds which have been identified and catalogued.
Of these, only a small percent have ever been investigated with respect to their general …

Quantitative structure-activity relationship studies on anticancer drugs

SP Gupta - Chemical reviews, 1994 - ACS Publications
Cancer is one of the most formidable diseases of the world. In fact, if there is any disease
which the mankind is still most afraid of it is cancer. Cancer is not one disease, but a group …

Design, synthesis and high antitumor potential of new unsymmetrical bisacridine derivatives towards human solid tumors, specifically pancreatic cancers and their …

E Paluszkiewicz, B Horowska, B Borowa-Mazgaj… - European Journal of …, 2020 - Elsevier
New promising unsymmetrical bisacridine derivatives (UAs), have been developed. Three
groups including 36 compounds were synthesized by the condensation of 4-nitro or 4 …

Some new 1-nitro acridine derivatives as antimicrobial agents

L Ngadi, AM Galy, JP Galy, J Barbe, A Crémieux… - European journal of …, 1990 - Elsevier
Some new 1-nitro acridine derivatives were prepared and characterized. These compounds
were screened for evaluating their antimicrobial properties against Gram+ bacteria, Gram …

The interactions of monomeric acridines and unsymmetrical bisacridines (UAs) with DNA duplexes: an insight provided by NMR and MD studies

T Laskowski, M Kosno, W Andrałojć, JE Frackowiak… - Scientific Reports, 2023 - nature.com
Members of a novel class of anticancer compounds, exhibiting high antitumor activity, ie the
unsymmetrical bisacridines (UAs), consist of two heteroaromatic ring systems. One of the …

Synthesis and antitumor activity of conjugates of muramyldipeptide, normuramyldipeptide, and desmuramylpeptides with acridine/acridone derivatives

K Dzierzbicka, AM Kołodziejczyk… - Journal of medicinal …, 2001 - ACS Publications
The synthesis of two groups (Chart 1, types A and B) of conjugates of MDP
(muramyldipeptide) and nor-MDP (normuramyldipeptide) with acridine/acridone derivatives …

Cytotoxic and antitumor activity of 1-nitroacridines as an aftereffect of their interstrand DNA cross-linking

K Pawlak, JW Pawlak, J Konopa - Cancer research, 1984 - AACR
To determine whether the toxic effects and changes in many cell functions caused by
antitumor 1-nitroacridines are related to their enzymatically mediated covalent interstrand …

Products of metabolic activation of the antitumor drug ledakrin (nitracrine) in vitro

K Gorlewska, Z Mazerska, P Sowiński… - Chemical Research in …, 2001 - ACS Publications
The aim of this work was to characterize the products of metabolic activation of the antitumor
drug ledakrin (Nitracrine) in model metabolic systems, where formation of drug− DNA …

Drug uptake and cellular targets of hydroxymethylacylfulvene (HMAF)

MCS Herzig, B Arnett, JR MacDonald… - Biochemical …, 1999 - Elsevier
Hydroxymethylacylfulvene (HMAF, MGI 114) is a novel antitumor drug and a potent pro-
apoptotic agent that has the potential to alkylate cellular nucleophiles. The objective of these …